Intelligent Investor

Invitrocue Limited (ASX: IVQ) - Announcements

DELISTED - Current share price for IVQ : $0.060

ASX company news and announcements for Invitrocue Limited (IVQ) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Invitrocue Limited (IVQ) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Invitrocue Limited (IVQ), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Invitrocue Limited (IVQ)

Market Cap ($m) Headline Announcement date/time + Price at ann'ment + Current price + Price
7D Avg
Gain/Loss
- IVQ signs strategic partnership agreement with QIAGEN Suzhou 22 Aug 2016 7:04PM $0.095 $0.060 $0.060 fallen by 36.84%
- Escrow release 16 Aug 2016 3:30PM $0.090 $0.060 $0.060 fallen by 33.33%
- IVQ announces new program focused on Hepatitis B virus 28 Jul 2016 2:06PM $0.065 $0.060 $0.060 fallen by 7.69%
- Appendix 4C - quarterly 28 Jul 2016 10:46AM $0.065 $0.060 $0.060 fallen by 7.69%
- IVQ commences Pancreatic Toxicity Assay development 12 Jul 2016 9:20AM $0.065 $0.060 $0.060 fallen by 7.69%
- Change of auditor 7 Jul 2016 9:39AM $0.062 $0.060 $0.060 fallen by 3.23%
- IVQ publishes Human Stem Cell Derived Hepatocytes results 24 May 2016 12:46PM $0.100 $0.060 $0.060 fallen by 40%
- IVQ Convenes Scientific and Medical Advisory Board 20 May 2016 12:12PM $0.100 $0.060 $0.060 fallen by 40%
- Investor Presentation 16 May 2016 10:25AM $0.100 $0.060 $0.060 fallen by 40%
- IVQ Announces Malaria Initiative 16 May 2016 10:20AM $0.100 $0.060 $0.060 fallen by 40%
- IVQ Expands 3D Cell-based Platform for Oncology 12 May 2016 12:01PM $0.100 $0.060 $0.060 fallen by 40%
- Appendix 4C - quarterly 27 Apr 2016 10:10AM $0.070 $0.060 $0.060 fallen by 14.29%
- Appendix 3B (Revised) 30 Mar 2016 7:47PM $0.080 $0.060 $0.060 fallen by 25%
- Initial Director's Interest Notice 24 Mar 2016 3:43PM $0.080 $0.060 $0.060 fallen by 25%
- Director Appointment 24 Mar 2016 2:58PM $0.080 $0.060 $0.060 fallen by 25%
- Appendix 3B 23 Mar 2016 1:19PM $0.080 $0.060 $0.060 fallen by 25%
- Becoming a substantial holder - Steven Fang 15 Mar 2016 11:17AM $0.085 $0.060 $0.060 fallen by 29.41%
- Agreement with London School of Hygiene & Tropical Medicine 9 Mar 2016 9:27AM $0.110 $0.060 $0.060 fallen by 45.45%
- Operations update 7 Mar 2016 9:18AM $0.100 $0.060 $0.060 fallen by 40%
- Half Yearly Report and Accounts 29 Feb 2016 6:14PM $0.080 $0.060 $0.060 fallen by 25%
- Operations update 16 Feb 2016 5:15PM $0.080 $0.060 $0.060 fallen by 25%
- Investor presentation 15 Feb 2016 1:15PM $0.080 $0.060 $0.060 fallen by 25%
- Operations update 8 Feb 2016 2:56PM $0.105 $0.060 $0.060 fallen by 42.86%
- Becoming a substantial holder - Clearbridge Accelerator 2 Feb 2016 3:22PM $0.105 $0.060 $0.060 fallen by 42.86%
- Becoming a substantial holder 2 Feb 2016 9:00AM $0.105 $0.060 $0.060 fallen by 42.86%

176 - 200 of 200 results

Page 8 of 8

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.